> *The following text is extracted and transformed from the technologynetworks.com privacy policy that was archived on 2016-03-15. Please check the [original snapshot on the Wayback Machine](https://web.archive.org/web/20160315080102id_/http%3A//www.technologynetworks.com/privacy.aspx) for the most accurate reproduction.*

# Technology Networks - The Online Scientific Community - Privacy Policy and Disclaimer

This website and its affiliated micro-sites are owned and published by Technology Networks Ltd.

To ensure that you get the most from our website, we are committed to optimizing the site to match your needs, so it is easier for you to find the content and services most relevant to your work and keeping access to most of our content and services free of charge. We endeavour to exceed the strict privacy practices required by the United States CAN-SPAM Act of 2003, the United Kingdom Data Protection Act and the 2002 European Directive on Privacy and Electronic Communications. If, however, you would like to make a query regarding our privacy policy please [contact us](mailto:support@technologynetworks.com?subject=Privacy%20Policy%20Query).

**Information we collect from you**

Site visitors are required to complete a registration process. By registering, visitors provide us with information about who they are, the work they do, and their interests. Once registration is complete no further information of this sort is required for free access to this site. Further personal information from visitors may be required to participate in the online Forums. We may also collect information regarding your use of the websites by monitoring the use of cookies.

**How we use Personal Information**

The information that we gather is used in a variety of ways. The first is to build up a demographic profile of our membership, allowing us to better match our content and services to the interests of our members. Obviously, the more accurate the information provided by each member, the better we can do this. For this reason, visitors are encouraged to regularly update their profiles to provide us with the most accurate information possible.

We may disclose your information to other companies in order to ensure the smooth provision of services that you have booked with us. If you have made a booking with us your data will be principally used to provide you with your purchase as well as your registration or other services and facilities.

Your details may be shared within the Technology Networks and Select Biosciences group. Please [click here](https://web.archive.org/web/20160315080102id_/http%3A//www.technologynetworks.com/about.aspx) for a list of websites and company details. These companies may use your details to send you information about products, promotions and special offers that we think may interest you.

The information is also used in our dealings with the third parties with whom we work. The co-operation of the companies that supply us with content and services and the revenue derived from advertising and sponsorship allow us to keep access to our sites free of charge. In order to provide incentives for these third parties to continue working with us, Technology Networks Ltd. does share some information about our visitors, as detailed below.

We may monitor the activity of visitors accessing the site and share data about this activity with publishers and advertisers. However, personal data about an individual member is only provided to third parties if the visitor has given us prior consent to do so by ticking the relevant box in our registration form.

Personal data about individual members is never shared with a third party we do not consider to be reputable and is only made available to companies who are actively supporting free access to the content and services provided by our sites. Visitors should note however that, if they enter another site from a link within a Technology Networks Ltd. site, they are no longer covered by this privacy policy.

**How you can access and update your data**

We have designed our websites so that it is easy for you to access and update the personal information that you saved with us. After you log in you will be provided with a link that will allow you to access and update your details. Individual eNewsletters can be immediately unsubscribed by clicking an unsubscribe link within them. If you require further assistance on updating your details please [contact us](mailto:support@technologynetworks.com?subject=Details%20Update%20Help).

**Changes to this policy**

If at any point we decide to use your personally identifiable information in any way other that described in this privacy policy we will notify you by way of email or by 30 days notice on the website. Please note that we retain the right to change this policy at any time. Technology Networks Ltd. continues to invest in the best quality security available and we do our utmost to protect visitor privacy. If you have any queries regarding this privacy policy or the way we collect and gather information about our members, please e-mail your comments and questions to [support@technologynetworks.com](mailto:support@technologynetworks.com?subject=Comments%20and%20Questions%20for%20Technology%20Networks)

| 

[**Taking Gene Editing by Storm**](https://web.archive.org/web/20160315080102id_/http%3A//www.technologynetworks.com/news.aspx?id=189102)  
Gene Editing – the ability to remove or replace genes in living organisms – has been a leading driver in molecular biology. The recent emergence of CRISPR/Cas9 significantly lowers the workflow and expertise barrier. 

* * *

[**Prostate Cancer Surgery Improved**](https://web.archive.org/web/20160315080102id_/http%3A//www.technologynetworks.com/news.aspx?id=189293)  
Researchers at UT Southwestern Medical Center have determined that light reflectance spectroscopy can differentiate between malignant and benign prostate tissue with 85 percent accuracy, a finding that may lead to real-time tissue analysis during prostate cancer surgery.

* * *

[ **Faster UVA Molecular Analysis Technology**](https://web.archive.org/web/20160315080102id_/http%3A//www.technologynetworks.com/news.aspx?id=189294)  
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level. 

* * *

[**Properties of Light Can be Controlled by Nanostructures**](https://web.archive.org/web/20160315080102id_/http%3A//www.technologynetworks.com/news.aspx?id=189295)  
A study led by the UPV/EHU-University of the Basque Country professor Ángel Rubio has simulated a new device to generate terahertz radiation using carbon nanostructures.

* * *

[ **Infrared Spectrometer ‘Engine’ for Developers**](https://web.archive.org/web/20160315080102id_/http%3A//www.technologynetworks.com/news.aspx?id=189296)  
Si-Ware Systems has launched volume production of the smallest, lowest-cost infra-red spectrometer “engine” for developers. 

* * *

[**Spotted Gar Genome Links Humans to Vertebrate Ancestry**](https://web.archive.org/web/20160315080102id_/http%3A//www.technologynetworks.com/news.aspx?id=189314)  
Surviving ancestral qualities of the Gar genome are informative about evolution of many other animals too - including humans.

* * *

[ **Gene Identified that May Worsen Cancer Outcome**](https://web.archive.org/web/20160315080102id_/http%3A//www.technologynetworks.com/news.aspx?id=189321)  
Some patients with breast cancer, lung cancer and leukaemia seem to fare poorly after treatment because of the effects of a particular gene, a new study finds.

* * *

[ **Scientists Synthesize Anti-Cancer Agent**](https://web.archive.org/web/20160315080102id_/http%3A//www.technologynetworks.com/news.aspx?id=189323)  
A team led by Rice University synthetic organic chemist K.C. Nicolaou has developed a new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria.

* * *

[ **Reducing Pediatric HIV Infection Rates in Africa**](https://web.archive.org/web/20160315080102id_/http%3A//www.technologynetworks.com/news.aspx?id=189326)  
Mother-to-child transmission of the human immunodeficiency virus (HIV), which causes AIDS, is still a major problem in resource-limited, rural areas of the world where health care providers are scarce.

* * *

[ **First Step in Design of New Anti-Cancer Drugs**](https://web.archive.org/web/20160315080102id_/http%3A//www.technologynetworks.com/news.aspx?id=189330)  
New research has identified a first step in the design of a new generation of anti-cancer drugs that include an agent to inhibit resistance to their effectiveness.

* * *
